Hjem › Myelodysplastiske syndromer › New Jersey › Edison
Kliniske studier for Myelodysplastiske syndromer i Edison, NJ
7 studier for Myelodysplastiske syndromer søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
- START New Jersey, East Brunswick · 6 mi unna
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi unna
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, New Brunswick · 3 mi unna
Myelodysplastiske syndromer-studier i andre byer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Tampa, FL19 studier
- Boston, MA19 studier
- Miami, FL17 studier
- Durham, NC14 studier
- Columbus, OH14 studier
- St. Louis, MO13 studier
- Atlanta, GA13 studier
Andre studier i Edison
- Brystkreft68 studier
- Ikke-småcellet lungekreft47 studier
- Kreft (alle typer)33 studier
- Prostatakreft29 studier
- Kolorektal kreft23 studier
- Lungekreft23 studier
- Multipelt myelom22 studier
- Blærekreft21 studier
- Akut myelogen leukemi20 studier
- Eggstokkreft20 studier
- Metastatisk kreft20 studier
- Endometriekreft19 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.